Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple applications for replication-defective herpes simplex virus vectors.

E A Burton1, J B Wechuck, S K Wendell

  • 1University of Pittsburgh School of Medicine, Department of Molecular Genetics and Biochemistry, Pittsburgh, Pennsylvania 15261, USA.

Stem Cells (Dayton, Ohio)
|September 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Novel Oncolytic Herpes Simplex Virus Design based on the Common Overexpression of microRNA-21 in Tumors.

Journal of gene therapy·2018
Same author

Rotational Energy as Mass in H_{3}^{+} and Lower Limits on the Atomic Masses of D and ^{3}He.

Physical review letters·2018
Same author

Effects of herpes simplex virus vectors encoding poreless TRPV1 or protein phosphatase 1α in a rat cystitis model induced by hydrogen peroxide.

Gene therapy·2017
Same author

Gene therapy-from small beginnings to where we are now.

Gene therapy·2017
Same author

MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats.

Gene therapy·2017
Same author

Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Gene therapy·2016
Same journal

Brent A. Reynolds, pioneer of adult neural stem cell biology.

Stem cells (Dayton, Ohio)·2026
Same journal

CircVapa promotes the abnormal differentiation of small intestinal epithelial stem cells in diabetic state.

Stem cells (Dayton, Ohio)·2026
Same journal

Transforming Growth Factor beta-2 (TGFβ2) Drives Trabecular Meshwork Progenitor Cell Differentiation Through SMAD2/3 Signalling.

Stem cells (Dayton, Ohio)·2026
Same journal

Circular RNA circEGFR overexpression attenuates chemosensitivity and enhances cancer stemness via targeting IGF2BP2/SOX2 in breast cancer cells.

Stem cells (Dayton, Ohio)·2026
Same journal

Regeneration of the mammalian brain: a relic of evolution?

Stem cells (Dayton, Ohio)·2026
Same journal

Mitochondrial transfer technologies with molecular insights into clinical applications.

Stem cells (Dayton, Ohio)·2026
See all related articles

Replication-defective Herpes simplex virus (HSV) vectors efficiently deliver therapeutic genes to neural and non-neural tissues, offering long-term expression and potential treatments for neurological diseases and malignancies.

Area of Science:

  • Virology
  • Gene Therapy
  • Neuroscience

Background:

  • Herpes simplex virus (HSV) is a neurotropic DNA virus with a large genome, allowing for transgene insertion.
  • HSV establishes a latent phase, maintaining its genome episomally in neuronal nuclei without disrupting function.

Purpose of the Study:

  • To construct nonpathogenic gene therapy vectors based on HSV.
  • To evaluate the efficacy of these vectors in delivering therapeutic transgenes to various tissues.

Main Methods:

  • Generation of replication-defective HSV vectors.
  • Testing vector efficacy in animal models for neurological diseases and other conditions.

Main Results:

  • Demonstrated efficient transgene delivery to neural and non-neural tissues.

Related Experiment Videos

  • Achieved sustained transgene expression, with reporter gene expression lasting over a year in the nervous system.
  • Showcased correction or prevention of neurodegeneration, chronic pain, peripheral neuropathy, and malignancy in animal models.

    • Conclusions:

    • Replication-defective HSV vectors are effective and flexible for transgene delivery.
    • These vectors have broad applications in treating neurological disorders, cancer, and in non-neural tissue for protein synthesis.
    • Emerging applications include stem cell modification for differentiation and systemic gene delivery.